1-(2-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidine

Catalog No.: 
ACKFVO408
CAS No.: 
1366131-49-8
Molecular Formula: 
C18H28BNO2
Molecular Weight: 
301.24
1-(2-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$515.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(2-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidine
IUPAC Name1-(2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidine
MDL No.MFCD16840940
Molecular FormulaC18H28BNO2
Molecular Weight301.24
SMILESCC1(C)C(C)(C)OB(C2=CC=C(N3CCCCC3)C(C)=C2)O1
InChI KeyAATUHVLQZIQRGE-UHFFFAOYSA-N
Synonym1-(2-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidine;Piperidine, 1-[2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-
CAS No.1366131-49-8

Synthetic Route by SureRoute

1. ACKFVO408 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKFVO408 route product structure diagram
    ACKFVO4081366131-49-8
Inquiry

2. ACKFVO408 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKFVO408 route product structure diagram
    ACKFVO4081366131-49-8
Inquiry

3. ACKFVO408 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKFVO408 route product structure diagram
    ACKFVO4081366131-49-8
Inquiry

Comments (0)